东星医疗
(301290)
| 流通市值：19.15亿 | | | 总市值：28.15亿 |
| 流通股本：6816.38万 | | | 总股本：1.00亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 92,804,243.6 | 295,179,331.27 | 169,822,069.79 | 200,288,963.78 |
| 应收票据及应收账款 | 85,776,867.66 | 94,462,846.05 | 96,491,481.41 | 94,681,813.9 |
| 其中：应收票据 | 663,838.03 | 2,716,349.66 | 4,446,626.96 | 2,462,654.13 |
| 应收账款 | 85,113,029.63 | 91,746,496.39 | 92,044,854.45 | 92,219,159.77 |
| 应收款项融资 | 2,938,232.6 | 3,384,643.87 | 598,261.53 | 3,361,586.18 |
| 预付款项 | 13,971,537.75 | 8,971,668.38 | 18,158,118.92 | 12,845,897.54 |
| 其他应收款合计 | 797,400 | 873,322.14 | 516,168.89 | 435,931.46 |
| 存货 | 120,681,366.2 | 111,450,051.23 | 120,626,531.45 | 108,616,171.22 |
| 合同资产 | 2,008,357.25 | 2,128,704.25 | 384,990.5 | 430,948.75 |
| 其他流动资产 | 2,141,453.76 | 1,034,979.02 | 681,465.2 | 1,887,441.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,427,814,741.49 | 1,423,545,701.77 | 1,405,254,383.76 | 1,379,878,172.58 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 12,500,000 | 10,000,000 | - | - |
| 投资性房地产 | 64,392,039.34 | 65,149,075.99 | 53,976,210.29 | 54,666,350.27 |
| 固定资产 | 185,269,951.78 | 188,222,968.6 | 183,196,829.69 | 187,434,744.74 |
| 在建工程 | 168,077,897.85 | 168,088,873.68 | 130,643,714.17 | 104,930,060.26 |
| 使用权资产 | 2,154,074.34 | 2,297,679.3 | 2,366,533.16 | 2,506,764.59 |
| 无形资产 | 81,988,217.84 | 85,847,661.52 | 101,475,760.75 | 105,365,339.2 |
| 商誉 | 533,930,880.45 | 533,930,880.45 | 533,930,880.45 | 533,930,880.45 |
| 长期待摊费用 | 22,565.58 | 30,227.22 | 202,659.7 | 36,971.01 |
| 递延所得税资产 | 4,630,062.42 | 4,646,166.95 | 6,056,783.99 | 4,128,776.37 |
| 其他非流动资产 | 50,233.24 | 678,789.77 | 463,316.2 | 274,000 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,053,015,922.84 | 1,058,892,323.48 | 1,012,312,688.4 | 993,273,886.89 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,480,830,664.33 | 2,482,438,025.25 | 2,417,567,072.16 | 2,373,152,059.47 |
| 流动负债: | | | | |
| 短期借款 | 64,479,337.35 | 33,026,006.58 | 16,315,109.46 | 13,729,263.65 |
| 应付票据及应付账款 | 101,635,257.6 | 130,705,926.26 | 114,155,522.14 | 92,484,071.85 |
| 其中：应付票据 | 21,872,560.45 | 21,696,573.38 | 17,251,748.41 | 16,154,147.86 |
| 应付账款 | 79,762,697.15 | 109,009,352.88 | 96,903,773.73 | 76,329,923.99 |
| 预收款项 | 1,250,000 | 1,250,000 | - | - |
| 合同负债 | 8,950,434.93 | 6,893,839.41 | 8,787,564.23 | 7,403,350.87 |
| 应付职工薪酬 | 9,823,239.4 | 19,390,146.52 | 16,297,738.9 | 14,062,768.94 |
| 应交税费 | 7,906,549.06 | 14,416,489.67 | 13,674,064 | 14,947,097.77 |
| 其他应付款合计 | 621,214.21 | 612,522.33 | 1,525,585.86 | 1,387,549.05 |
| 一年内到期的非流动负债 | 403,287.71 | 698,141.91 | 496,447.77 | 496,447.77 |
| 其他流动负债 | 1,689,902.41 | 2,611,898.43 | 3,559,069.36 | 2,830,922.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 196,759,222.67 | 209,604,971.11 | 174,811,101.72 | 147,341,472.58 |
| 非流动负债: | | | | |
| 租赁负债 | 2,121,740.78 | 1,812,861.96 | 1,746,626.3 | 2,061,891.46 |
| 递延收益 | 9,648,831.15 | 9,866,138.2 | 9,779,715.8 | 9,984,601.23 |
| 递延所得税负债 | 7,069,787.62 | 7,596,568.97 | 8,127,302.47 | 8,650,131.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 18,840,359.55 | 19,275,569.13 | 19,653,644.57 | 20,696,624.38 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 215,599,582.22 | 228,880,540.24 | 194,464,746.29 | 168,038,096.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 100,173,334 | 100,173,334 | 100,173,334 | 100,173,334 |
| 资本公积 | 1,695,708,566.16 | 1,695,708,566.16 | 1,696,698,006.35 | 1,696,698,006.35 |
| 减:库存股 | 29,991,845.57 | 29,991,845.57 | 29,991,845.57 | 29,991,845.57 |
| 盈余公积 | 50,086,667 | 50,086,667 | 50,086,667 | 50,369,138.71 |
| 未分配利润 | 442,684,570.47 | 430,620,595.25 | 398,774,298.46 | 380,593,179.72 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,258,661,292.06 | 2,246,597,316.84 | 2,215,740,460.24 | 2,197,841,813.21 |
| 少数股东权益 | 6,569,790.05 | 6,960,168.17 | 7,361,865.63 | 7,272,149.3 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,265,231,082.11 | 2,253,557,485.01 | 2,223,102,325.87 | 2,205,113,962.51 |
| 负债和股东权益合计 | 2,480,830,664.33 | 2,482,438,025.25 | 2,417,567,072.16 | 2,373,152,059.47 |
| 公告日期 | 2025-04-25 | 2025-04-15 | 2024-10-25 | 2024-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |